Market Access Strategy for Medical Devices in Europe
Strategic recommendations on the topic of market access pathways for medical devices and IVD tests
White Paper: Evidence Requirements for the Creation of IVD Reimbursement (NABM) Codes in France
Get insights from MTRC White Papers to advance your understanding on HAS assessments and evidence generation strategy for IVD tests in France
Recent news and posts
Publication Digest: French reimbursement of health technologies: assessment is at the heart of the procedure
MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest.
In a recent publication, Carbonneil et al. analyzed the key stages of health technologies (including medical devices and in-vitro diagnostics) reimbursement in France, outlining the process from regulatory authorization to health technology assessment and final reimbursement decision. The study highlighted that assessment by the French National Authority for Health (HAS) is central to all procedures and serves as an essential tool for ensuring safe, effective, and affordable patient access. The authors noted that with evolving European regulations (HTAR), the French system will require continual adaptation to maintain timely and equitable healthcare access.
Access the full-text article here.